Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Expert Review of Pharmacoeconomics & Outcomes Research|May 1, 2009
Applying Programme Budgeting Marginal Analysis in the health sector: 12 years of experienceRachel Grocott
International Journal of Environmental Research and Public Health|July 10, 2010
Comments on "Simoens, S. Health economic assessment: a methodological primer. Int. J. Environ. Res. Public Health 2009, 6, 2950-2966"-New Zealand in fact has no cost-effectiveness thresholdScott Metcalfe, Rachel Grocott
The New Zealand Medical Journal|October 15, 2005
Going against the flow: the impact of PHARMAC not funding COX-2 inhibitors for chronic arthritisRachel Grocott, Scott Metcalfe
The New Zealand Medical Journal|September 19, 2013
Assessing the value for money of pharmaceuticals in New Zealand--PHARMAC's approach to cost-utility analysisRachel Grocott, Scott Metcalfe, Paul Alexander, et al.
Pageof 1